NetScientific PLC Grant of Options to Directors (4148V)
30 Janeiro 2017 - 5:01AM
UK Regulatory
TIDMNSCI
RNS Number : 4148V
NetScientific PLC
30 January 2017
("NetScientific" or the "Company" or the "Group")
Grant of Options to Directors
London, UK - 30(th) January 2017 - NetScientific plc
("NetScientific", AIM: NSCI), the transatlantic biomedical and
healthcare technology group, today announced that on 27(th) January
2017, options over ordinary shares of 5p each were granted to its
CEO François Martelet and CFO Ian Postlethwaite as detailed below
(the "New Options").
Director Number of Options Number of Options
Granted Held
------------------------ -------------------- ------------------
François Martelet 200,000 759,020
Ian Postlethwaite 180,000 360,000
The New Options have an exercise price of 65.5 pence per share,
being the average closing price for the ordinary shares over the
five dealing days prior to the date on which the options were
granted. The New Options vest three years from the date of
grant.
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet, M.D.,
CEO
Ian Postlethwaite, CFO
Stifel Nicolaus Europe Limited Tel: +44 (0) 20 7710
(NOMAD and broker) 7600
Jonathan Senior / David Arch
/ Ben Maddison
Consilium Strategic Communications Tel: +44 (0)20 3709 5700
Mary-Jane Elliott / Jessica netscientific@consilium-comms.com
Hodgson / Chris Welsh
About NetScientific Plc
NetScientific is a transatlantic healthcare technology group
with an investment strategy focused on sourcing, funding and
commercialising technologies that significantly improve the health
and well-being of people with chronic diseases. For more
information, please visit the website at www.netscientific.net
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDBGDBDDDBGRC
(END) Dow Jones Newswires
January 30, 2017 02:01 ET (07:01 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024